I took a trip down memory lane this afternoon and re-read this paper that started the journey for monepantel.
2014 / Uni of NSW/St George Hospital.
While it was analysing monepantel in ovarian cancer cell lines, it revealed the role MPL plays in suppression of the mTOR/p70S6K signalling pathway, and provided the first evidence to show that MPL triggers autophagy.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163620/
Well worth another read for those who are new to PAA and are delving into the science.
PAA, A New Dawn , FDA ODD Approval and Entering Phase II MND Trial, page-569
Add NUZ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.015(7.89%) |
Mkt cap ! $98.34M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.5¢ | $37.89K | 188.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 84794 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 111434 | 4 |
View Market Depth
| Last trade - 11.36am 15/11/2024 (20 minute delay) ? |
| NUZ (ASX) Chart |